JP3056881B2 - Virucidal agents and their use - Google Patents

Virucidal agents and their use

Info

Publication number
JP3056881B2
JP3056881B2 JP4108992A JP10899292A JP3056881B2 JP 3056881 B2 JP3056881 B2 JP 3056881B2 JP 4108992 A JP4108992 A JP 4108992A JP 10899292 A JP10899292 A JP 10899292A JP 3056881 B2 JP3056881 B2 JP 3056881B2
Authority
JP
Japan
Prior art keywords
chloride
virus
virucidal
effect
ibdv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4108992A
Other languages
Japanese (ja)
Other versions
JPH05279261A (en
Inventor
令二 関
Original Assignee
令二 関
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 令二 関 filed Critical 令二 関
Priority to JP4108992A priority Critical patent/JP3056881B2/en
Publication of JPH05279261A publication Critical patent/JPH05279261A/en
Application granted granted Critical
Publication of JP3056881B2 publication Critical patent/JP3056881B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、IBDVのための殺ウ
イルス剤およびその使用法に関する。
FIELD OF THE INVENTION The present invention relates to a virucidal agent for IBDV and its use.

【0002】[0002]

【従来技術】鶏伝染性ファブリキウス嚢病は1957年
に米国東南部の養鶏地帯に初発生したウイルス性の感染
病で、免疫抑制を起こす性質があるため、その被害は大
きく現在ではさらに病原性の強いIBDVの発生流行が
アメリカ、ヨーロッパからアジア、および我が国でも1
990年以降起っている。このIBDVはウイルスの形
質上抵抗性が強く、現在市販されている殺菌消毒剤およ
びその旧知の用法では殺ウイルス効果は期待しにくい。
一般的に広く使われている界面活性剤の類(いわゆる逆
性石ケンおよび両性石ケン)にいたっては、IBDVを
消毒、不活性化するには効果なしと言われ、これがある
程度常識になっていた。逆性石ケンである第4級アンモ
ニウム塩の「塩化ジアルキルジメチルアンモニウム」に
おいても実際にIBDVに対して殺ウイルス効果がない
ものとされていた。
BACKGROUND OF THE INVENTION Chicken infectious bursal disease is a viral infectious disease that first occurred in a poultry farm in the southeastern United States in 1957 and has the property of causing immunosuppression. Strong IBDV outbreak is one in America, Europe to Asia and Japan
It has happened since 990. This IBDV has a strong viral resistance, and it is difficult to expect a virucidal effect with currently marketed disinfectants and their known uses.
It is said that surfactants generally used widely (so-called inverted soaps and amphoteric soaps) have no effect on disinfecting and inactivating IBDV, and this has become common sense to some extent. I was It has been reported that the quaternary ammonium salt “dialkyldimethylammonium chloride” which is an inverse soap actually has no virucidal effect on IBDV.

【0003】[0003]

【目的】本発明は、IBDVに対してすぐれた殺ウイル
ス効果を示す新らしい殺ウイルス剤とその使用法に関す
る。
The present invention relates to a novel virucidal agent having excellent virucidal effect on IBDV and its use.

【0004】[0004]

【構成】本発明の第一は、一般式、The first aspect of the present invention is a general formula:

【化2】 で示される塩化ジアルキルジメチルアンモニウム(式
中、R1とR2はいずれもアルキル基であり、同一または
異っていてもよい。)とアルカリ剤を含有することを特
徴とする鶏伝染性ファブリキウス嚢病ウイルス(以下I
BDVと略称する)に対する殺ウイルス剤に関する。前
記塩化ジアルキルジメチルアンモニウムにおけるアルキ
ル基としてはC8以上、とくにC8〜C12のものが好まし
い。具体的化合物としては例えば塩化ジオクチルジメチ
ルアンモニウム、塩化オクチルデシルジメチルアンモニ
ウム、塩化ジデシルジメチルアンモニウムなどを挙げる
ことができるがそのなかでもとくに塩化ジデシルジメチ
ルアンモニウムが好ましい。
Embedded image Characterized in that it contains a dialkyldimethylammonium chloride represented by the formula (wherein R 1 and R 2 are both alkyl groups and may be the same or different), and an alkali agent. Disease virus (hereinafter I
BDV). It said C 8 or higher alkyl group in a chloride dialkyldimethylammonium, particularly those of C 8 -C 12 are preferred. Specific compounds include, for example, dioctyldimethylammonium chloride, octyldecyldimethylammonium chloride, didecyldimethylammonium chloride, and among them, didecyldimethylammonium chloride is particularly preferred.

【0005】[0005]

【実施例】【Example】

〈使用菌株〉 PV1株:イタリアにおいて発生したIBDの鶏から分
離されたIBDVで、CAMで62代、CKで23代継
代したものを使用した。この株はIBDV1型に属す
る。 〈鶏および発育鶏卵〉隔離鶏舎で維持されているPDL
−1系の4〜8週齢のヒナをCK用として使用した。C
AM用に10日齢のPDL−1系の発育鶏卵を使用し
た。 〈CK培養法〉CKの増殖培地には、イーグルMEM培
地「ニッスイ」に0.3%の割合のトリプトースホスフ
ェート培地(TPB)を加え、さらに抗生物質(ペニシ
リン100U/ml、カナマイシン100μg/ml、
およびファンギゾン0.5μg/ml)、0.15%炭
酸水素ナトリウムおよび5%小牛血清を添加して使用し
た。維持用培地には、イーグルMEM培地「ニッスイ」
に抗生物質および0.15%炭酸水素ナトリウムを加え
たものを使用した。消化液は、クエン酸緩衝液にトリプ
シン(Difco, 1:250)を0.05%の割合に溶解して使
用した。培養には、4〜8週齢のSPF鶏の腎を無菌的
に取り出し、消化し、細胞を遠心により厚め、その容積
を測って0.25−0.3%の割合に浮遊させた。細胞
浮遊液を5mlずつシャーレ(直径55mm)に分注
し、5%炭酸ガスおよび湿度を含む37℃の炭酸ガス鶏
卵器内で培養した。培養開始後2日でウイルス接種およ
び実験に使用した。 〈ウイルス継代〉ウイルス株の継代は、前記により準備
したCKで行い、LE(0.5%のラクトアルブミン水
解物、2μg/mlのアンホテリシンB、200U/m
lのペニシリンおよび200μg/mlのストレプトマ
イシンを含むアール緩衝液)で10倍に希釈したウイル
ス液を0.4mlシャーレに接種し、1時間炭酸ガス鶏
卵器内に置いた後、接種ウイルス液を抜き取り、維持用
培地を5ml加え、4日間培養した。細胞変性効果(C
PE)の現われた細胞を培養液共々回収し、−40℃に
置いて凍結させた後融解し、超音波処理を行った。それ
を遠心した上清をウイルス液として、同様の操作を3〜
4回行いウイルスの継代を行った。 〈ウイルス力価測定〉ウイルス力価は準備したCKを用
いて、ブラック法により行なった。LEで10倍階段希
釈したウイルス液をウイルス継代と同様にCKに接種し
た。接種ウイルス液を除いた後、約50℃に調製した
0.8%の寒天(Bacto agar)、0.3%のTPB、抗
生物質および5%小牛血清を含むイーグルMEM培地を
5ml重層し3日間培養した。培養3日目に、約50℃
に調製した0.8%の寒天、0.3%のTPB、抗生物
質および1%のニュートラルレッドを含むイーグルME
M培地を5ml重層し、翌日ブラック数を数えた。ブラ
ック形成単位(PFU)はlog/mlで示した。
<Bacterial strain> PV1 strain: IBDV isolated from chickens of IBD that occurred in Italy and used for 62 generations in CAM and 23 generations in CK was used. This strain belongs to type IBDV1. <Hens and embryonated eggs> PDL maintained in an isolated chicken house
A 4-8 week old chick of line -1 was used for CK. C
A 10-day-old embryonated chicken egg of the PDL-1 line was used for AM. <CK culture method> To the growth medium of CK, a tryptose phosphate medium (TPB) at a ratio of 0.3% was added to the Eagle MEM medium “Nissui”, and further, antibiotics (penicillin 100 U / ml, kanamycin 100 μg / ml,
And fungizone (0.5 μg / ml), 0.15% sodium bicarbonate and 5% calf serum. For maintenance medium, Eagle MEM medium “Nissui”
To which an antibiotic and 0.15% sodium bicarbonate were added. The digestion solution was prepared by dissolving trypsin (Difco, 1: 250) in a citrate buffer at a ratio of 0.05%. For culture, kidneys of 4-8 week old SPF chickens were aseptically removed, digested, cells were thickened by centrifugation, and their volumes were measured and suspended at a rate of 0.25-0.3%. Each 5 ml of the cell suspension was dispensed into a petri dish (55 mm in diameter) and cultured in a 37 ° C. carbon dioxide egg containing 5% carbon dioxide and humidity. Two days after the start of the culture, the cells were used for virus inoculation and experiments. <Viral passage> The passage of the virus strain was performed using CK prepared as described above, and LE (0.5% lactalbumin hydrolyzate, 2 μg / ml amphotericin B, 200 U / m
1 ml of penicillin and 200 μg / ml of streptomycin in Earl's buffer solution), and inoculate a 0.4 ml petri dish with a virus solution diluted 10-fold, place in a carbon dioxide egg container for 1 hour, and withdraw the inoculated virus solution. 5 ml of a maintenance medium was added and cultured for 4 days. Cytopathic effect (C
The cells in which PE) appeared were collected together with the culture solution, frozen at −40 ° C., thawed, and sonicated. The same operation was repeated for 3 to
The virus was passaged four times. <Virus titer measurement> The virus titer was measured by the black method using the prepared CK. CK was inoculated with the virus solution serially diluted 10-fold with LE in the same manner as the virus passage. After removing the inoculated virus solution, 5 ml of Eagle's MEM medium containing 0.8% agar (Bacto agar), 0.3% TPB, antibiotics and 5% calf serum prepared at about 50 ° C. was overlaid. Cultured for days. On the third day of culture, at about 50 ° C.
Eagle ME containing 0.8% agar, 0.3% TPB, antibiotics and 1% neutral red prepared in
The M medium was overlaid with 5 ml, and the number of blacks was counted the next day. Black forming units (PFU) are given in log / ml.

【0006】〈実施方法〉実験1では式<Implementation method> In Experiment 1, the equation

【化3】 で示される塩化ジデシルジメチルアンモニウムの希釈液
とウイルス液を0.4mlずつ1:1の割合で接触さ
せ、以下の実験では消毒薬希釈液とウイルス液を0.3
mlずつ1:1の割合で接触させた。塩化ジデシルメチ
ルアンモニウムの濃度を下記の表のとおりの三種類の濃
度とし、アルカル剤として水酸化ナトリウムを用い、そ
の濃度を0.05%として使用した。IBDVに対する
効果はつぎのとおりである。
Embedded image The diluted solution of didecyldimethylammonium chloride and the virus solution were contacted at a ratio of 1: 1 by 0.4 ml each.
Contact was made at a ratio of 1: 1 for each ml. The concentrations of didecylmethylammonium chloride were three concentrations as shown in the table below, sodium hydroxide was used as an alkaline agent, and the concentration was 0.05%. The effects on IBDV are as follows.

【表1】 * 残存ウイルス価はlog10PFU/mlで表わし
た。 **殺ウイルス度については、残存ウイルス価で ×は3.4 log10以上のもの(効果なし) △は2.4〜3.4 log10のもの(ほとんど効果な
し) ○は1.4〜2.4 log10のもの(やゝ効果あり) ◎は1.4 log10以下のもの(大へん効果あり) として示した。アルカリ剤併用の効果を確認するため、
水酸化ナトリウムの濃度をいろいろに変えて同様の試験
を行った。その結果はつぎの表のとおりである。
[Table 1] * Residual virus titers were expressed as log 10 PFU / ml. For ** virucidal index, × in residual virus titer 3.4 log 10 or more of (no effect) △ those (almost no effect) of 2.4 to 3.4 log 10 ○ is 1.4 2.4 log 10 (having a ゝ effect) ◎ is 1.4 log 10 or less (having a great effect). In order to confirm the effect of using an alkali agent,
A similar test was conducted with various concentrations of sodium hydroxide. The results are shown in the following table.

【表2】 [Table 2]

【0007】〈比較例〉前記実施例と同一の要領で、塩
化ジデシルジメチルアンモニウム塩のかわりに式
<Comparative Example> In the same manner as in the above-mentioned Example, instead of didecyldimethylammonium chloride, a formula

【化4】 で示される(R3はC数9〜15)〔モノおよびビス
(塩化トリメチルアンモニウムメチレン)〕−アルキル
(C9〜C15)トルエンを用いて試験した結果をつぎの
表に示す。
Embedded image (R 3 is a C number of 9 to 15) [mono and bis (trimethylammonium chloride methylene)]-alkyl (C 9 to C 15 ) toluene represented by the following formula is shown in the following table.

【表3】 [Table 3]

【0008】[0008]

【効果】本発明は、単独では殺菌効果がないのに、2成
分を併用することにより、優れた殺菌効果をもつ新しい
殺ウイルス剤を提供することができた。
According to the present invention, a novel virucidal agent having an excellent bactericidal effect can be provided by using two components in combination, although the bactericidal effect is not obtained by itself.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61P 31/12 171 A61P 31/12 171 (58)調査した分野(Int.Cl.7,DB名) A61K 33/00 A01N 33/12 A01N 59/00 A61K 31/14 A61L 2/18 A61P 31/12 CAPLUS(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 7 identification code FI A61P 31/12 171 A61P 31/12 171 (58) Investigated field (Int.Cl. 7 , DB name) A61K 33/00 A01N 33 / 12 A01N 59/00 A61K 31/14 A61L 2/18 A61P 31/12 CAPLUS (STN) REGISTRY (STN)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 一般式 【化1】 で示される塩化ジアルキルジメチルアンモニウム(式中
1とR2はいずれもアルキル基であり、同一または異っ
ていてもよい。)とアルカリ剤を含有することを特徴と
する鶏伝染性ファブリキウス嚢病ウイルス(以下IBD
Vと略称する)に対する殺ウイルス剤。
1. A compound of the general formula Characterized by containing a dialkyldimethylammonium chloride represented by the formula (wherein R 1 and R 2 are both alkyl groups and may be the same or different) and an alkali agent, Virus (hereinafter IBD)
V).
【請求項2】 塩化ジアルキルジメチルアンモニウムが
塩化ジデシルジメチルアンモニウムである請求項1記載
の殺ウイルス剤。
2. The virucidal agent according to claim 1, wherein the dialkyldimethylammonium chloride is didecyldimethylammonium chloride.
【請求項3】 塩化ジアルキルジメチルアンモニウムと
アルカル剤を含有する溶液を畜舎に適用することを特徴
とする畜舎の消毒法。
3. A method of disinfecting a barn, which comprises applying a solution containing a dialkyldimethylammonium chloride and an alkali agent to the barn.
JP4108992A 1992-04-01 1992-04-01 Virucidal agents and their use Expired - Lifetime JP3056881B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4108992A JP3056881B2 (en) 1992-04-01 1992-04-01 Virucidal agents and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4108992A JP3056881B2 (en) 1992-04-01 1992-04-01 Virucidal agents and their use

Publications (2)

Publication Number Publication Date
JPH05279261A JPH05279261A (en) 1993-10-26
JP3056881B2 true JP3056881B2 (en) 2000-06-26

Family

ID=14498846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4108992A Expired - Lifetime JP3056881B2 (en) 1992-04-01 1992-04-01 Virucidal agents and their use

Country Status (1)

Country Link
JP (1) JP3056881B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014156267A (en) * 2013-02-18 2014-08-28 Univ Of Yamanashi Packing method and packing device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL372273A1 (en) * 2002-01-18 2005-07-11 Lonza Ag Virucidal disinfectant
RU2290208C2 (en) * 2004-11-16 2006-12-27 Елена Борисовна Иванова Multifunctional foam composition for integrated special treatment of surfaces, rooms, and objects against dangerous agents and substances

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014156267A (en) * 2013-02-18 2014-08-28 Univ Of Yamanashi Packing method and packing device

Also Published As

Publication number Publication date
JPH05279261A (en) 1993-10-26

Similar Documents

Publication Publication Date Title
Winterfield et al. Infectivity and distribution of infectious bursal disease virus in the chicken. Persistence of the virus and lesions
Cook The classification of new serotypes of infectious bronchitis virus isolated from poultry flocks in Britain between 1981 and 1983
Allwright et al. Isolation of an influenza A virus from ostriches (Struthio camelus)
Cook et al. A live attenuated turkey rhinotracheitis virus vaccine. 1. Stability of the attenuated strain
US7462479B2 (en) Infectious bronchitis virus vaccine
Cook Fowl adenoviruses: Studies on aspects of the pathogenicity of six strains for 1‐day‐old chicks
Williams et al. Further studies on the development of a live attenuated vaccine against turkey rhinotracheitis
JP3056881B2 (en) Virucidal agents and their use
EP0023922B1 (en) Heterotypic canine parvovirus vaccine
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
Wood et al. The interaction of live vaccine and maternal antibody in protection against infectious bursal disease
Meyer et al. Characteristics of a psittacosis viral agent isolated from a turkey.
KR0127116B1 (en) Infections brusal disease vaccine
KR100531491B1 (en) Bovine Respiratory Coronavirus As a Vaccine
Amin et al. Infection of the chicken with a virulent or avirulent strain of Mycoplasma gallisepticum alone and together with Newcastle disease virus or E. coli or both
GB1599612A (en) Antiviral agent and treatment of viral infections
US5686287A (en) Marek&#39;s disease virus vaccine
JP2721005B2 (en) Mixed live vaccine
Allan et al. Some characteristics of a natural infection by parainfluenza-3 virus in a group of calves
Montgomery et al. Observations on the pathogenicity of Alcaligenes faecalis in chickens
Heckert et al. Experimental infection of emus (Dromaiius novaehollandiae) with avian influenza viruses of varying virulence: clinical signs, virus shedding and serology
EP0802796A1 (en) Chicken anaemia agent broiler vaccine
Harry et al. Laboratory and field trials on a formalin inactivated vaccine for the control of Pasteurella anatipestifer septicaemia in ducks
Kim et al. The isolation of lentogenic strains of Newcastle disease virus in Australia
Motha et al. Outbreak of atypical fowlpox in chickens with persistent reticuloendotheliosis viraemia

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090414

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090414

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110414

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120414

Year of fee payment: 12

EXPY Cancellation because of completion of term
R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154